Published in Neuropharmacology on January 01, 2005
Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci U S A (2011) 1.12
Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology (2008) 1.02
G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res (2008) 0.97
Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling. PLoS One (2013) 0.85
mGlu Receptors and Cancerous Growth. Wiley Interdiscip Rev Membr Transp Signal (2011) 0.84
Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes. Pigment Cell Melanoma Res (2013) 0.82
Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer. PLoS One (2014) 0.82
Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One (2013) 0.81
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression. Transl Oncol (2015) 0.79
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell (2006) 11.79
Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88
Autophagy suppresses tumorigenesis through elimination of p62. Cell (2009) 9.95
Autophagy and metabolism. Science (2010) 8.10
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43
Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev (2007) 7.41
Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev (2007) 6.35
Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev (2003) 3.67
Role of autophagy in cancer: management of metabolic stress. Autophagy (2007) 3.40
Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal (2010) 3.38
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell (2005) 3.19
Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem (2002) 3.18
A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol (2010) 2.93
Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev (2013) 2.90
Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev (2004) 2.69
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell (2002) 2.64
Metabolic catastrophe as a means to cancer cell death. J Cell Sci (2007) 2.58
Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev (2002) 2.29
The role for autophagy in cancer. J Clin Invest (2015) 2.11
Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev (2011) 2.09
Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov (2013) 2.08
Autophagy-mediated tumor promotion. Cell (2013) 2.08
ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J (2007) 1.90
Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem (2002) 1.82
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res (2007) 1.82
Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol (2010) 1.76
A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res (2006) 1.74
Tumor suppression by autophagy through the management of metabolic stress. Autophagy (2008) 1.71
Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Mol Syst Biol (2013) 1.56
BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev (2005) 1.55
NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev (2007) 1.53
Exploiting different ways to die. Genes Dev (2004) 1.51
Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling. Oncogene (2005) 1.51
Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal (2005) 1.50
Immortalized mouse epithelial cell models to study the role of apoptosis in cancer. Methods Enzymol (2008) 1.47
Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate (2008) 1.45
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate (2010) 1.45
Role of autophagy in cancer prevention. Cancer Prev Res (Phila) (2011) 1.43
Role of autophagy in breast cancer. Autophagy (2007) 1.39
Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS One (2012) 1.37
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res (2008) 1.37
ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol Cell Biol (2003) 1.34
Why sick cells produce tumors: the protective role of autophagy. Autophagy (2007) 1.34
Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov (2013) 1.32
Role of the polarity determinant crumbs in suppressing mammalian epithelial tumor progression. Cancer Res (2008) 1.30
Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity. J Biol Chem (2009) 1.30
Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem (2006) 1.30
Cloning and characterization of a novel gene, SHPRH, encoding a conserved putative protein with SNF2/helicase and PHD-finger domains from the 6q24 region. Genomics (2003) 1.25
A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res (2009) 1.24
Bak and Bax function to limit adenovirus replication through apoptosis induction. J Virol (2002) 1.24
Autophagic cell death unraveled: Pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy (2008) 1.14
Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res (2014) 1.13
Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism. Anal Chem (2011) 1.13
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy (2012) 1.12
Production of membrane proteins for NMR studies using the condensed single protein (cSPP) production system. J Struct Funct Genomics (2009) 1.12
Assessing metabolic stress and autophagy status in epithelial tumors. Methods Enzymol (2009) 1.11
Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner. Mol Cell Biol (2013) 1.10
Progressive appearance of pigmentation in amelanotic melanoma lesions. Pigment Cell Res (2002) 1.08
Identification and characterization of mouse Rab32 by mRNA and protein expression analysis. Biochim Biophys Acta (2003) 1.07
Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate (2012) 1.07
A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression. Methods Enzymol (2008) 1.05
Hyperoxia sensing: from molecular mechanisms to significance in disease. J Immunotoxicol (2010) 1.05
Measurement of subcellular texture by optical Gabor-like filtering with a digital micromirror device. Opt Lett (2008) 1.04
Induction of apoptosis by diterpenes from the soft coral Xenia elongata. J Nat Prod (2007) 1.03
Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology (2008) 1.02
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling. Bioorg Med Chem (2012) 1.02
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. Clin Cancer Res (2011) 1.01
Bcl-2 modulation to activate apoptosis in prostate cancer. Mol Cancer Res (2009) 1.01
E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S. J Virol (2003) 1.01
Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. Cancer Res (2010) 0.98
Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. J Biol Chem (2005) 0.98
Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res (2007) 0.97
G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res (2008) 0.97
Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors. Mol Cancer Res (2010) 0.96
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res (2009) 0.95